Alexandria Venture Investments, LLC

Insider Reports History

Location: Pasadena, CA
Signature: By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Company	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Singular Genomics Systems, Inc.	10%+ Owner	Common stock	2,645,985	$1,120,310	$0.4234	01 Jun 2021	Direct
Vigil Neuroscience, Inc.	10%+ Owner	Common stock	192,973	$723,649	$3.75	11 Jan 2022	Direct
Xilio Therapeutics, Inc.	10%+ Owner	Common stock	166,423	$138,131	$0.8300	26 Oct 2021	Direct
Singular Genomics Systems, Inc.	10%+ Owner	Series A convertible preferred stock	0			01 Jun 2021	Direct
Singular Genomics Systems, Inc.	10%+ Owner	Series B convertible preferred stock	0			01 Jun 2021	Direct
Vigil Neuroscience, Inc.	10%+ Owner	Series A convertible preferred stock	0			11 Jan 2022	Direct
Vigil Neuroscience, Inc.	10%+ Owner	Series B convertible preferred stock	0			11 Jan 2022	Direct
Xilio Therapeutics, Inc.	10%+ Owner	Series B convertible preferred stock	0			26 Oct 2021	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Role	Filing Time
VIGL	Vigil Neuroscience, Inc.	11 Jan 2022	3	$0	4	10%+ Owner	11 Jan 2022, 16:53
VIGL	Vigil Neuroscience, Inc.	06 Jan 2022	0	$0	3	10%+ Owner	06 Jan 2022, 18:31
XLO	Xilio Therapeutics, Inc.	26 Oct 2021	2	$0	4	10%+ Owner	26 Oct 2021, 16:51
XLO	Xilio Therapeutics, Inc.	21 Oct 2021	0	$0	3	10%+ Owner	21 Oct 2021, 20:59
/report/000172202421000008-alexandria-venture-investments-llc-2021-06-01	Singular Genomics Systems, Inc.	01 Jun 2021	3	$0	4	10%+ Owner	01 Jun 2021, 17:22
/report/000172202421000006-alexandria-venture-investments-llc-2021-05-26	Singular Genomics Systems, Inc.	26 May 2021	0	$0	3	10%+ Owner	26 May 2021, 21:59